Back to ESPR

Esperion Therapeutics, Inc. 8-K

Accession 0001628280-25-009619

Filing information

CIK
0001434868
Report date
2025-03-04
Filing date
2025-03-04
Form
8-K
Primary document
espr-20250304.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.